First Affiliated Hospital Xi'an Jiaotong University

This study looks at whether removing blood clots from heart arteries during a heart attack procedure (called PPCI) can reduce the risk of future heart problems. About 6,760 adults with a severe type of heart attack (STEMI) and large clots will be randomly assigned to get either s…

This early-phase study tests a new type of immune cell therapy (bispecific AbTCR-T cells) in 3 adults with relapsed or refractory B-cell lymphoma. The cells are designed to recognize two targets (CD19 and CD22) on cancer cells. The main goal is to check safety and side effects, w…

This study tests whether adding thiotepa to the standard melphalan treatment before a stem cell transplant can reduce the chance of cancer returning in people with multiple myeloma who still have signs of disease. About 204 adults aged 18-70 will be randomly assigned to receive e…

This study tests whether giving a clot-busting drug (rhPro-UK) before a standard clot-removal procedure helps stroke patients recover better. About 820 adults with a large-vessel blockage will receive either the drug or a placebo within 4.5 to 24 hours of their first symptoms. Th…

This study aims to see if a new test that measures electrical and mechanical signals from the heart can accurately diagnose valvular heart disease. Researchers will recruit 1,300 adults with and without valve problems to compare the new test against standard echocardiography. If …